Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol infusion versus conservative treatment in severe intracerebral hemorrhage
IRCT20200208046414N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of propofol in intracerebral hematoma (ICH) (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoints: Mean modified Rankin Scale, National Institutes of Health Stroke Scale and 6 more. Started Apr 2020; status: completed.
02
Drugs
propofol
03
Conditions
intracerebral hematoma (ICH)
Beyond the preview
Go deeper on IRCT20200208046414N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200208046414N1.